Last reviewed · How we verify

NCT05686785: HEPSCAN

Agreement and Reliability of Transient Elastography

Recruiting now Last updated 4 October 2023
What this trial tests

trial testing Transient elastography in Chronic Viral Hepatitis in 300 participants. Currently enrolling.

Timeline
1 June 2023
Primary endpoint
1 February 2026
1 December 2026

Quick facts

Lead sponsorLund University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date1 June 2023
Primary completion1 February 2026
Estimated completion1 December 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Lund University

Who can join

18 and older, any sex, with Chronic Viral Hepatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess agreement, smallest detectable change, and reliability of repeated measurements of liver stiffness of transient elastography in patients with chronic viral hepatitis, and to explore factors associated with disagreement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transient elastography

Trials testing the same drug.

Other recruiting trials for Chronic Viral Hepatitis

Currently open trials in the same condition.

Other Lund University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05686785.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing